genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Artificial Intelligence
From Model to Molecule: NVIDIA Doubles Down on AI Drug Discovery
AgBio
Let There Be Light: GreenLight Strives for Global RNA Equity to…
Coronavirus
Icosavax: Giving VLPs the VIP Treatment
CRISPR
Inscripta Eyes Broader Genome Editing Reach with $150M Series E
Drug Discovery
You Can See Manhattan from Your Lab: $3B “Cove” Campus Announced…
News
Companies
Thermo Fisher to Acquire PPD for $17.4B, as CROs Consolidate Further
Genetics
Curbing Malaria’s Spread by Genetic Engineering
Alzheimers
Loss of Pleasure Linked to Early-Onset Dementia Not Alzheimer’s, New Study…
Alzheimers
Potential Blood Biomarker for TBI, and Mechanistic Link with Alzheimer’s Disease…
Cell Therapy
New Hyaluronic Acid Therapy Presents Chemical and Mechanical Cues Healing Injured…
Insights
All
Trends for 2020
Trends for 2021
Antisense
n-Lorem Makes Ultrarare Disease Treatment Personal
Bioprocessing
Getting the Most Out of Your Intensified Bioprocess
Antibodies
Whence the Facility Expansions?
Bioprocessing
CDMOs Embrace Innovative Tech to Create “Digital Threads”
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
mRNA
mRNA
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
eBooks
The mRNA Therapeutics Boom
mRNA
Anima Biotech Heads for the Light with Up-to-$2.4B Takeda Partnership
mRNA
Translate Bio Continues Trial of Inhaled Cystic Fibrosis mRNA Despite Setback
mRNA
Ribosomes Shown Translating mRNA from Maternally Inherited Mitochondrial Genome
mRNA
OliX Advancing in Nucleic Acid Therapeutics
mRNA
Bayer Joins CureVac to Develop mRNA-Based COVID-19 Vaccine
mRNA
FDA Authorizes Emergency Use of Moderna’s COVID-19 Vaccine
mRNA
FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine
mRNA
FDA Set to Authorize Emergency Use of Pfizer/BioNTech COVID-19 Vaccine
mRNA
Molecular Underpinnings of Memory Now Better Understood
mRNA
Pfizer, BioNTech Gain Temporary U.K. Authorization for COVID-19 Vaccine
mRNA
Moderna Seeking Emergency Use Authorization for COVID-19 Vaccine
mRNA
Pfizer, BioNTech Seek Emergency Use Authorization for COVID-19 Vaccine
mRNA
Pfizer, BioNTech Report 95% Final Efficacy for COVID-19 Vaccine
mRNA
Moderna COVID-19 Vaccine 94.5% Effective in Early Phase III Data
1
2
3
...
10
Page 1 of 10
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
